We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 196

La Cour suprême du Canada rejette le premier appel entendu visant une réclamation en dommages-intérêts au titre de l’article 8

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 29 2015

Le 20 avril 2015, la Cour suprême du Canada a rejeté l’appel de Sanofi-Aventis à l’égard d’une action intentée par Apotex en vue de réclamer des

Supreme Court of Canada dismisses first section 8 damages appeal

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 28 2015

On April 20, 2015, the Supreme Court of Canada dismissed Sanofi-Aventis' appeal concerning a claim by Apotex for section 8 damages under the Patented

Applications for leave to appeal dismissed - 23 April 2015

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 23 2015

On appeal from the Court of Appeal for British Columbia. In 2007, the applicant was charged with, and convicted of, sexual assault after having

CIPO issues revised examination guidance on methods of medical treatment and dosage regimens

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • March 20 2015

The Canadian Intellectual Property Office (CIPO) has now released Practice Notice PN 2015-01, which relates to examination of medical treatment

Canadian patent law: 2014 year in review

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • March 18 2015

This article summarises noteworthy Canadian patent law decisions and developments from 2014. Court of Appeal addresses patent utility in Celebrex The

Re-examination: a viable alternative in Canada

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • March 13 2015

The Federal Court of Appeal recently upheld the dismissal of an appeal from a decision of a Patent Re-examination Board thus establishing that

Canadian patent law: 2014 year in review

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 26 2015

Canadian Courts have continued to address allegations that patents are invalid because they lack utility. A notable 2014 Court of Appeal decision in

Revue de l'année 2014 en matière de brevets

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 26 2015

Les tribunaux canadiens ont continué de se pencher sur des allégations selon lesquelles certains brevets sont invalides pour motif d’absence

Federal Court rejects NIA defence and awards compound interest on patent damages

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • January 24 2015

On Jan. 23, 2015, the Federal Court released its decision regarding the quantum of damages recoverable by Eli Lilly (“Lilly”) in an action relating

Canada prepares for Patent Law Treaty

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • January 14 2015

The Patent Act is undergoing amendment courtesy of Bill C-43, known as the Economic Action Plan 2014 Act, No 2, tabled in the House of Commons on